PTPN13 and hepatocellular carcinoma: Increased PTPN13 expression was observed in only 34 (32.69%) HCC samples compared with 70 (67.31%) normal tissue samples, while increased IGF2PB1 expression was observed in 73 (70.20%) HCC samples compared with only 31 (29.80%) normal tissue samples.